This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epidemiology

Authoring team

Accurate estimates of incidence and prevalence are difficult to achieve due to difficulties faced in identifying the disease.
It is estimated that (1):

  • around 50 million people worldwide have epilepsy out of which close to 90% of cases are seen in developing regions (2)
  • around 600,000 people in the UK are diagnosed with epilepsy and take anti epileptic drugs. This is equivalent to around 1 in 103 people (9.7 per 1,000 or 0.97 %). According to 2010 population estimates the prevalence rate in each country is as follows
    • in England - 1 in 105 people (0.95 %)
    • in Wales - 1 in 94 people (1.06 %)
    • in Scotland - 1 in 97 people (1.03%)
    • in Northern Ireland - 1 in 90 people (1.11%) (3)

The incidence of epilepsy in

  • UK is estimated to be 51 per 100,000 per year which is equivalent to around
    • 32,000 new cases diagnosed per year
    • 87 new cases each day of the year (based on 2010 population) (3)
  • United States - 44 out of 100,000 persons
  • sub-Saharan Africa - 63 to 158 out of 100,000 persons (4)

Epilepsy may affect people of all ages. But most commonly it develops in childhood (with more than half of patients developing seizures before the age of 15). A second peak can be observed in patients who are over 60 years (almost a quarter of people with newly diagnosed epilepsy) (5)

About 70% of patients with epilepsy are successfully treated with established anti-epileptic drugs, over 50% of these patients will eventually be able to stop medication. The annual cost of epilepsy in the UK is £2 billion

 

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.